Scientific Publications
2012
Maresca KP, Hillier SM, Lu G, Marquis JC, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW. Small Molecule Inhibitors of PSMA Incorporating Technetium-99m for Imaging Prostate Cancer: Effects of Chelate Design on Pharmacokinetics. Inorganica Chimica Acta 389 (2012) 168-175.
Babich JW, Joyal JL, Coleman RE, (2012) Targeting Prostate Cancer with Small Molecule Inhibitors of Prostate-Specific Membrane Antigen. In MJ Welch & WC Eckelman (Eds.) Targeted Molecular Imaging (pp. 161-174). Boca Raton: CRC Press - Taylor and Francis Group, LLC.
2011
Hillier SM, Kern AM, Maresca KP, Marquis JC, Eckelman WC, Joyal JL, Babich JW. [123I] MIP-1072, a Small-Molecule Inhibitor of Prostate Specific Membrane Antigen, is Effective at Monitoring Tumor Response to Taxane Therapy. Journal of Nuclear Medicine 2011 52:1087-1093.
Roach M 3rd, Alberini JL, Pecking AP, Testori A, Verrecchia F, Soteldo J, Ganswindt U, Joyal JL, Babich JW, Witte RS, Unger E, Gottlieb R. Diagnostic and Therapeutic Imaging for Cancer: Therapeutic Considerations and Future Directions. Journal of Surgical Oncology, 2011 May 1;103(6):587-601.
2009
Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N, Zimmerman CN, Barrett JA, Eckelman WC, Pomper MG, Joyal JL, Babich JW. Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues that Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer. Cancer Research 2009 Sep 1; 69(17): 6932-40.
Maresca KP, Hillier SM, Femia FJ, Zimmerman CN, Levadala MK, Banerjee SR, Hicks J, Sundararajan C, Valliant J, Zubieta J, Eckelman WC, Joyal JL, Babich JW. Comprehensive Radiolabeling, Stability, and Tissue Distribution Studies of Technetium-99m Single Amino Acid Chelates (SAAC). Bioconjugate Chemistry 2009 Jul 2; 20 (8): 1625-1633.
Maresca KP, Hillier SM, Femia FJ, Keith D, Barone C, Joyal JL, Zimmerman CN, Kozikowski AP, Barrett JA, Eckelman WC, Babich JW. A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer. Journal of Medicinal Chemistry 2009 Jan 22; 52(2): 347-57.